☰

Yang Zong, Ph.D. - Publications

Affiliations: 
2007 University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Cell Biology, Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Zong Y, Goldstein AS, Witte ON. Tissue Recombination Models for the Study of Epithelial Cancer. Cold Spring Harbor Protocols. 2015: pdb.top069880. PMID 26631129 DOI: 10.1101/Pdb.Top069880  0.369
2015 Lawson DA, Werb Z, Zong Y, Goldstein AS. The Cleared Mammary Fat Pad Transplantation Assay for Mammary Epithelial Organogenesis. Cold Spring Harbor Protocols. 2015: pdb.prot078071. PMID 26631119 DOI: 10.1101/Pdb.Prot078071  0.33
2015 Faltermeier CM, Drake JM, Clark PM, Smith BA, Zong Y, Volpe C, Mathis C, Morrissey C, Castor B, Huang J, Witte ON. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proceedings of the National Academy of Sciences of the United States of America. PMID 26621741 DOI: 10.1073/Pnas.1521674112  0.347
2015 Zong Y, Goldstein AS, Witte ON. Dissociated Prostate Regeneration under the Renal Capsule. Cold Spring Harbor Protocols. 2015: pdb.prot078063. PMID 26527760 DOI: 10.1101/Pdb.Prot078063  0.351
2015 Zong Y, Goldstein AS, Witte ON. Preparation of Urogenital Sinus Mesenchymal Cells for Prostate Tissue Recombination Models. Cold Spring Harbor Protocols. 2015: pdb.prot078055. PMID 26527759 DOI: 10.1101/Pdb.Prot078055  0.379
2015 Faltermeier C, Drake J, Clark P, Smith B, Mathis C, Zong Y, Volpe C, Witte O. Abstract 5183: Identification and characterization of wild type kinases driving prostate cancer metastasis Cancer Research. 75: 5183-5183. DOI: 10.1158/1538-7445.Am2015-5183  0.311
2013 Smith DA, Kiba A, Zong Y, Witte ON. Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues. Molecular Cancer Research : McR. 11: 1159-65. PMID 23867565 DOI: 10.1158/1541-7786.Mcr-13-0238  0.362
2013 Zong Y, Goldstein AS, Huang J. The molecular basis for ethnic variation and histological subtype differences in prostate cancer. Science China. Life Sciences. 56: 780-7. PMID 23852643 DOI: 10.1007/S11427-013-4522-0  0.332
2013 Zong Y, Goldstein AS. Adaptation or selection--mechanisms of castration-resistant prostate cancer. Nature Reviews. Urology. 10: 90-8. PMID 23247694 DOI: 10.1038/Nrurol.2012.237  0.353
2012 Zong Y, Huang J, Sankarasharma D, Morikawa T, Fukayama M, Epstein JI, Chada KK, Witte ON. Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling. Proceedings of the National Academy of Sciences of the United States of America. 109: E3395-404. PMID 23184966 DOI: 10.1073/Pnas.1217982109  0.382
2012 Zong Y, Huang J, Witte ON. Abstract B67: The epigenetic regulator Hmga2 is sufficient to initiate prostate cancer via paracrine Wnt signaling Cancer Research. 72: B67-B67. DOI: 10.1158/1538-7445.Prca2012-B67  0.407
2012 Smith DA, Zong Y, Kiba A, Witte ON. Abstract B57: Oncostatin M promotes progression of Pten-deficient prostate cancer Cancer Research. 72: B57-B57. DOI: 10.1158/1538-7445.Prca2012-B57  0.371
2011 Campbell PK, Zong Y, Yang S, Zhou S, Rubnitz JE, Sorrentino BP. Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia. Leukemia Research. 35: 1321-9. PMID 21640380 DOI: 10.1016/J.Leukres.2011.05.004  0.571
2011 Memarzadeh S, Cai H, Janzen DM, Xin L, Lukacs R, Riedinger M, Zong Y, DeGendt K, Verhoeven G, Huang J, Witte ON. Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal. Proceedings of the National Academy of Sciences of the United States of America. 108: 7962-7. PMID 21518863 DOI: 10.1073/Pnas.1105243108  0.331
2011 Goldstein AS, Zong Y, Witte ON. A two-step toward personalized therapies for prostate cancer. Science Translational Medicine. 3: 72ps7. PMID 21368221 DOI: 10.1126/Scitranslmed.3002169  0.357
2010 Memarzadeh S, Zong Y, Janzen DM, Goldstein AS, Cheng D, Kurita T, Schafenacker AM, Huang J, Witte ON. Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proceedings of the National Academy of Sciences of the United States of America. 107: 17298-303. PMID 20855612 DOI: 10.1073/Pnas.1012548107  0.312
2010 Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proceedings of the National Academy of Sciences of the United States of America. 107: 2610-5. PMID 20133806 DOI: 10.1073/Pnas.0913873107  0.423
2009 Zong Y, Xin L, Goldstein AS, Lawson DA, Teitell MA, Witte ON. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 12465-70. PMID 19592505 DOI: 10.1073/Pnas.0905931106  0.4
2008 Lukacs RU, Lawson DA, Xin L, Zong Y, Garraway I, Goldstein AS, Memarzadeh S, Witte ON. Epithelial stem cells of the prostate and their role in cancer progression. Cold Spring Harbor Symposia On Quantitative Biology. 73: 491-502. PMID 19022743 DOI: 10.1101/Sqb.2008.73.012  0.379
2007 Zong Y, Zhou S, Sorrentino BP. Reply to 'Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels' by Widmer et al. [2] Leukemia. 21: 1562-1563. DOI: 10.1038/Sj.Leu.2404672  0.552
2006 Zong Y, Zhou S, Fatima S, Sorrentino BP. Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters. The Journal of Biological Chemistry. 281: 29625-32. PMID 16885162 DOI: 10.1074/Jbc.M606314200  0.596
2006 Zong Y, Zhou S, Sorrentino BP. Reply to Rumpold et al. Leukemia. 20: 144-145. PMID 16270041 DOI: 10.1038/Sj.Leu.2404002  0.501
2005 Zong Y, Zhou S, Sorrentino BP. Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia. Leukemia. 19: 1590-6. PMID 16001089 DOI: 10.1038/Sj.Leu.2403853  0.556
2005 Zhou S, Zong Y, Ney PA, Nair G, Stewart CF, Sorrentino BP. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood. 105: 2571-6. PMID 15546952 DOI: 10.1182/Blood-2004-04-1566  0.587
2005 Zong Y, Zhou S, Sorrentino BP. Lineage-Specific Expression of Mouse Abcg2 during Hematopoiesis Is Regulated by Alternative Use of Multiple Leader Exons and Promoters. Blood. 106: 4251-4251. DOI: 10.1182/blood.v106.11.4251.4251  0.576
2003 Zhou S, Zong Y, Lu T, Sorrentino BP. Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone. Biotechniques. 35: 1248-52. PMID 14682060 DOI: 10.2144/03356Ss04  0.556
Show low-probability matches.